A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. (Q35841455)
Jump to navigation
Jump to search
scientific article published on 29 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. |
scientific article published on 29 January 2012 |
Statements
A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy (English)
Rob J Van Geest
Sarit Y Lesnik-Oberstein
H Stevie Tan
Roel Goldschmeding
Cornelis J F Van Noorden
Ingeborg Klaassen
Reinier O Schlingemann
29 January 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference